Pr ecis: These findings identify a novel function for the signaling scaffold molecule STRAP as an activator of the NOTCH1-HES1 pathway that regulates cancer stem-like cells in colorectal cancer, with potential implications for prognosis and therapy.
Pr ecis: The patient iPSC-derived stem cell-based model described in this study will illuminate pathophysiology and therapeutic possibilities in cancers driven by mTOR pathway dysregulation.
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De Novo Lipid Synthesis Facilitates Gemcitabine Resistance through Endoplasmic Reticulum Stress in Pancreatic Cancer Saber Tadros, Surendra K. Shukla, Ryan J. King, Venugopal Gunda, Enza Vernucci, Jaime Abrego, Nina V. Chaika, Fang Yu, Audrey J. Lazenby, Lyudmyla Berim, Jean Grem, Aaron R. Sasson, and Pankaj K. Singh
Pr ecis: Our studies demonstrate that inhibition of de novo lipid synthesis in pancreatic cancer cells can overcome the resistance against fluropyrimidines such as gemcitabine, which are key constituents of pancreatic cancer chemotherapy, by inducing ER stress and decreasing the stemness of cancer cells.
5518
Sensitivity to BUB1B Inhibition Defines an Alternative Classification of Glioblastoma Eunjee Lee, Margaret Pain, Huaien Wang, Jacob A. Herman, Chad M. Toledo, Jennifer G. DeLuca, Raymund L. Yong, Patrick Paddison, and Jun Zhu Pr ecis: These findings offer a mechanism-based classification framework to predict the clinical course and therapeutic responses of glioblastomas.
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Loss of Tumor Suppressor STAG2 Promotes Telomere Recombination and Extends the Replicative Lifespan of Normal Human Cells
Zharko Daniloski and Susan Smith
Pr ecis: These findings reveal a mechanism in normal and premalignant cells that could prolong the period during which tumor-driving mutations can accumulate, thereby increasing risks of cancer. Pr ecis: This important study reports the use of circulating tumor cells to define a quantitative biomarker of tumor heterogeneity within an individual patient that can guide the choice of systemic treatment for metastatic castrationresistant prostate cancer.
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ABOUT THE COVER
The double staining of intracytoplasmic cytoskeleton cytokeratins and cleaved caspase-3 is a useful methodology to visualize cell death-related processes in tumors. Using immunofluorescence and confocal microscopy acquisition, it was found that treatment of EL-4 thymoma-bearing mice with a humanized antibody that recognizes Jagged 1 and 2 results in the coexpression of pan-cytokeratin (yellow) and cleaved caspase-3 (red) in the tumor. For details, see article by Sierra and colleagues on page 5628. To request permission to re-use all or part of this article, contact the AACR Publications Department at
